Literature DB >> 27923615

Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Brandon C Chapman1, Alessandro Paniccia1, Patrick W Hosokawa2, William G Henderson2, Douglas M Overbey1, Wells Messersmith3, Martin D McCarter1, Ana Gleisner1, Barish H Edil1, Richard D Schulick1, Csaba Gajdos4.   

Abstract

BACKGROUND: Previous studies have demonstrated improved in-hospital mortality after hepatic resection for hepatocellular carcinoma (HCC) at teaching hospitals. The objective of this study was to evaluate if resection of HCC at academic cancer programs (ACP) is associated with improved 10-year survival. STUDY
DESIGN: Using the National Cancer Data Base (NCDB) (1998 to 2011), we evaluated patients undergoing hepatic resection for HCC at ACPs, comprehensive community cancer programs (CCCPs), and community cancer programs (CCPs). High volume cancer programs (HVCPs) were defined as performing 10 or more hepatectomies per year. Multivariate Cox proportional hazard models by stepwise selection were applied to estimate hazard ratios (HR) of predictors of survival. The Kaplan-Meier method was used to generate survival curves at each facility type, and survival rates were compared using the log-rank test.
RESULTS: We identified 12,757 patients undergoing hepatic resection for HCC at ACPs (n = 8,404), CCPs (n = 483), and CCCPs (n = 3,870). Sixty-two percent (n = 5,191) of patients treated at ACPs were at high volume institutions compared with 11.6% (n = 446) and 0% of CCCPs and CCPs, respectively (p < 0.0001). On multivariable analysis, patients undergoing hepatic resection at transplant centers (p < 0.0001) and HVCPs had significantly improved survival (p < 0.0001). Adjusted 10-year survival rates were 28.7% at high volume ACPs, 28.2% at high volume CCCPs, 24.9% at low volume CCCPs, 25.1% at low volume ACPs, and 21.3% at CCPs (p ≤ 0.0001).
CONCLUSIONS: Patients undergoing hepatic resection for HCC at HVCPs had a significantly improved 10-year survival. Regionalization of HCC treatment to HVCPs may improve long-term survival. Copyright Â
© 2016 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27923615     DOI: 10.1016/j.jamcollsurg.2016.11.011

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  15 in total

1.  Outcomes After Resection of Hepatocellular Carcinoma: Intersection of Travel Distance and Hospital Volume.

Authors:  Eliza W Beal; Rittal Mehta; Katiuscha Merath; Diamantis I Tsilimigras; J Madison Hyer; Anghela Paredes; Mary E Dillhoff; Jordan Cloyd; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2019-05-08       Impact factor: 3.452

2.  Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States.

Authors:  Koji Matsuo; Shinya Matsuzaki; Rachel S Mandelbaum; Kazuhide Matsushima; Maximilian Klar; Brendan H Grubbs; Lynda D Roman; Jason D Wright
Journal:  Gynecol Oncol       Date:  2020-01-22       Impact factor: 5.482

3.  Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.

Authors:  Grace C Lee; T Clark Gamblin; Zhi Ven Fong; Cristina R Ferrone; Lipika Goyal; Keith D Lillemoe; Lawrence S Blaszkowsky; Kenneth K Tanabe; Motaz Qadan
Journal:  Ann Surg Oncol       Date:  2019-07-31       Impact factor: 5.344

4.  The clinical and economic burden of perioperative complications of radical cystectomy.

Authors:  Christine W Liaw; Jared S Winoker; Peter Wiklund; John Sfakianos; Matthew D Galsky; Reza Mehrazin
Journal:  Transl Androl Urol       Date:  2019-07

Review 5.  Effects of volume on outcome in hepatobiliary surgery: a review with guidelines proposal.

Authors:  Eloisa Franchi; Matteo Donadon; Guido Torzilli
Journal:  Glob Health Med       Date:  2020-10-31

6.  Trends in the Incidence, Treatment and Outcomes of Patients with Intrahepatic Cholangiocarcinoma in the USA: Facility Type is Associated with Margin Status, Use of Lymphadenectomy and Overall Survival.

Authors:  Lu Wu; Diamantis I Tsilimigras; Anghela Z Paredes; Rittal Mehta; J Madison Hyer; Katiuscha Merath; Kota Sahara; Fabio Bagante; Eliza W Beal; Feng Shen; Timothy M Pawlik
Journal:  World J Surg       Date:  2019-07       Impact factor: 3.352

7.  Improved survival for extremity soft tissue sarcoma treated in high-volume facilities.

Authors:  Tyler Abarca; Yubo Gao; Varun Monga; Munir R Tanas; Mohammed M Milhem; Benjamin J Miller
Journal:  J Surg Oncol       Date:  2018-04-06       Impact factor: 3.454

8.  Predicted effect of regionalised delivery care on neonatal mortality, utilisation, financial risk, and patient utility in Malawi: an agent-based modelling analysis.

Authors:  Mark G Shrime; Katherine R Iverson; Rachel Yorlets; Sanam Roder-DeWan; Anna D Gage; Hannah Leslie; Address Malata
Journal:  Lancet Glob Health       Date:  2019-07       Impact factor: 26.763

9.  Adoption of single agent anticancer therapy for advanced hepatocellular carcinoma and impact of facility type, insurance status, and income on survival: Analysis of the national cancer database 2004-2014.

Authors:  Aman Opneja; Gino Cioffi; Asrar Alahmadi; Nelroy Jones; Tin-Yun Tang; Nirav Patil; David L Bajor; Joel N Saltzman; Amr Mohamed; Eva Selfridge; Ankit Mangla; Jill Barnholtz-Sloan; Richard T Lee
Journal:  Cancer Med       Date:  2021-05-31       Impact factor: 4.711

10.  Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma.

Authors:  Benyuan Deng; Min Yang; Ming Wang; Zhongwu Liu
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.